Litsebi tsa tlhahiso le phepelo ea biopharmaceutical |Lisebelisoa tse tala |Li-Reagents tsa Pharmaceutical Intermediates |Lisebelisoa tsa k'hemistri |Polyimide monomers |
4,4′-(1,3-Phenylenedioxy)dianiline|CAS: 2479-46-1 |C18H16N2O2
Litsebi tsa tlhahiso le phepelo ea biopharmaceutical |Lisebelisoa tse tala |Li-Reagents tsa Pharmaceutical Intermediates |Indasteri Material Chemistry |Polyimide monomers |4,4′-(4,4′-Isopropylidenediphenyl-1,1′-diyldioxy)dianiline |CAS: 13080-86-9 |C27H26N2O2
Litsebi tsa tlhahiso le phepelo ea biopharmaceutical |Lisebelisoa tse tala |Li-Reagents tsa Pharmaceutical Intermediates |Mafu a pelo |Khatello ea Mali e Phahameng |S-ATBA |CAS: 109010-60-8 |C16H22N2O3
Litsebi tsa tlhahiso le phepelo ea biopharmaceutical |Lisebelisoa tse tala |Li-Reagents tsa Pharmaceutical Intermediates |Mafu a Neurological |Lithethefatsi tsa antiepileptic |(R) -2-amino-N-benzyl-3-methoxypropanamide (2R,3R) -dihydroxysuccinate |CAS: 1423058-53-0 |C15H22N2O8
Litsebi tsa tlhahiso le phepelo ea biopharmaceutical |Lisebelisoa tse tala |Li-Reagents tsa Pharmaceutical Intermediates |Mafu a Neurological |Lithethefatsi tsa antiepileptic |Lacosamide |CAS: 175481-36-4 |C13H18N2O3
Litsebi tsa tlhahiso le phepelo ea biopharmaceutical |Lisebelisoa tse tala |Li-Reagents tsa Pharmaceutical Intermediates |Indasteri API |Lithethefatsi tsa tsamaiso ea lijo |Itopride hydrochloride le li-Intermediates tsa eona |4-(2-Dimethylamino)ethoxybenzylamine |CAS: 20059-73-8 |Setšoantšo sa C11H18N2O
Litsebi tsa tlhahiso le phepelo ea biopharmaceutical |Lisebelisoa tse tala |Li-Reagents tsa Pharmaceutical Intermediates |Indasteri API |Lithethefatsi tsa tsamaiso ea lijo |Itopride hydrochloride le li-Intermediates tsa eona |Itopride |CAS: 122898-67-3 |Setšoantšo sa C20H26N2O4
Litsebi tsa tlhahiso le phepelo ea biopharmaceutical |Lisebelisoa tse tala |Li-Reagents tsa Pharmaceutical Intermediates |Indasteri API |Prostatic Hyperplasia Lithethefatsi |Tamsulosin Hydrochloride Intermediates |CAS: 3259-03-8 |C10H13BrO2
Litsebi tsa tlhahiso le phepelo ea biopharmaceutical |Lisebelisoa tse tala |Li-Reagents tsa Pharmaceutical Intermediates |Indasteri API |Prostatic Hyperplasia Lithethefatsi |Tamsulosin Hydrochloride Intermediates |CAS: 116091-63-5 |C10H13NO4S
Litsebi tsa tlhahiso le phepelo ea biopharmaceutical |Li-Reagents tsa Pharmaceutical Intermediates |Lisebelisoa tse tala |Mafu a ho hema |Pranlukast Intermediates |4-(4-Phenylbutoxy)benzoic acid |CAS: 30131-16-9 |C17H18O3
Litsebi tsa tlhahiso le phepelo ea biopharmaceutical |Li-Reagents tsa Pharmaceutical Intermediates |Lisebelisoa tse tala |Mafu a ho hema |Pranlukast Intermediates |3′-[4-(4-Phenylbutoxy)benzoylamino]-2′-hydroxyacetophenone |CAS: 136450-06-1 |C25H25NO4
Litsebi tsa tlhahiso le phepelo ea biopharmaceutical |Li-Reagents tsa Pharmaceutical Intermediates |Lisebelisoa tse tala |Mafu a ho hema |Pranlukast Intermediates |3'-Amino-2'-hydroxyacetophenone |CAS: 70977-72-9 |C8H9NO2